These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
720 related items for PubMed ID: 16109462
1. American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy. Small W, Erickson B, Kwakwa F. Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1502-7. PubMed ID: 16109462 [Abstract] [Full Text] [Related]
2. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study. Erickson B, Eifel P, Moughan J, Rownd J, Iarocci T, Owen J. Int J Radiat Oncol Biol Phys; 2005 Nov 15; 63(4):1083-92. PubMed ID: 16099599 [Abstract] [Full Text] [Related]
3. Vaginal brachytherapy for postoperative endometrial cancer: 2014 Survey of the American Brachytherapy Society. Harkenrider MM, Grover S, Erickson BA, Viswanathan AN, Small C, Kliethermes S, Small W. Brachytherapy; 2016 Nov 15; 15(1):23-9. PubMed ID: 26620818 [Abstract] [Full Text] [Related]
10. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T, Ito K, Saitoh J, Noda SE, Harashima K, Sakurai H, Nakayama Y, Yamamoto T, Suzuki K, Nakano T, Niibe H. Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):463-71. PubMed ID: 16168838 [Abstract] [Full Text] [Related]
11. Intravaginal 1-week high-dose-rate brachytherapy alone for Stages I-II endometrial cancer. Martínez-Monge R, Nagore G, Cambeiro M, Garrán C, Villafranca E, Jurado M. Brachytherapy; 2007 Oct 01; 6(3):195-200. PubMed ID: 17681240 [Abstract] [Full Text] [Related]
13. Vaginal vault brachytherapy as sole postoperative treatment for low-risk endometrial cancer. Chong I, Hoskin PJ. Brachytherapy; 2008 Oct 01; 7(2):195-9. PubMed ID: 18358790 [Abstract] [Full Text] [Related]
14. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience. Falkenberg E, Kim RY, Meleth S, De Los Santos J, Spencer S. Brachytherapy; 2006 Oct 01; 5(1):49-55. PubMed ID: 16563997 [Abstract] [Full Text] [Related]
17. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T, Katoh H, Noda SE, Ito K, Yamamoto T, Kashiwagi B, Nakano T. Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):472-8. PubMed ID: 16168839 [Abstract] [Full Text] [Related]
18. Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma. Fayed A, Mutch DG, Rader JS, Gibb RK, Powell MA, Wright JD, Elnaqa I, Zoberi I, Grigsby PW. Int J Radiat Oncol Biol Phys; 2007 Feb 01; 67(2):480-4. PubMed ID: 17141980 [Abstract] [Full Text] [Related]
19. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma--a prospective randomized study. Sorbe B, Horvath G, Andersson H, Boman K, Lundgren C, Pettersson B. Int J Radiat Oncol Biol Phys; 2012 Mar 01; 82(3):1249-55. PubMed ID: 21676554 [Abstract] [Full Text] [Related]